Personality and Quality of Life Amelioration After Continuous Subcutaneous Apomorphine Infusion in Parkinson ' s Disease

Conditions: Parkinson Disease Interventions: Other: Continuous subcutaneous apomorphine infusion (CSAI) Sponsors: University Hospital, Toulouse; ELIVIE France; EVER Pharma France SAS; NHC SAS, France; Orkyn ' ; ETPARK Association, Toulouse, France Not yet recruiting

https://clinicaltrials.gov/study/NCT06080399

Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

More News: France Health | Hospitals | Parkinson's Disease | Pharmaceuticals | Research